These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 30332466)

  • 1. Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational study.
    Gluck E; Nguyen HB; Yalamanchili K; McCusker M; Madala J; Corvino FA; Zhu X; Balk R
    PLoS One; 2018; 13(10):e0205924. PubMed ID: 30332466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands.
    Kip MMA; van Oers JA; Shajiei A; Beishuizen A; Berghuis AMS; Girbes AR; de Jong E; de Lange DW; Nijsten MWN; IJzerman MJ; Koffijberg H; Kusters R
    Crit Care; 2018 Nov; 22(1):293. PubMed ID: 30424796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum procalcitonin levels predict acute kidney injury in critically ill patients.
    Jeeha R; Skinner DL; De Vasconcellos K; Magula NP
    Nephrology (Carlton); 2018 Dec; 23(12):1090-1095. PubMed ID: 28967168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin and Bacterial Sepsis in Burn Patients in South Africa.
    Wineberg D; Moore R; Kruger D
    J Surg Res; 2020 Feb; 246():490-498. PubMed ID: 31635838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of Procalcitonin as a Sepsis Marker in a Community Hospital.
    De Oro N; Gauthreaux ME; Lamoureux J; Scott J
    J Appl Lab Med; 2019 Jan; 3(4):545-552. PubMed ID: 31639723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Interleukin-6 a better predictor of successful antibiotic therapy than procalcitonin and C-reactive protein? A single center study in critically ill adults.
    Weidhase L; Wellhöfer D; Schulze G; Kaiser T; Drogies T; Wurst U; Petros S
    BMC Infect Dis; 2019 Feb; 19(1):150. PubMed ID: 30760225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
    Kyriazopoulou E; Liaskou-Antoniou L; Adamis G; Panagaki A; Melachroinopoulos N; Drakou E; Marousis K; Chrysos G; Spyrou A; Alexiou N; Symbardi S; Alexiou Z; Lagou S; Kolonia V; Gkavogianni T; Kyprianou M; Anagnostopoulos I; Poulakou G; Lada M; Makina A; Roulia E; Koupetori M; Apostolopoulos V; Petrou D; Nitsotolis T; Antoniadou A; Giamarellos-Bourboulis EJ
    Am J Respir Crit Care Med; 2021 Jan; 203(2):202-210. PubMed ID: 32757963
    [No Abstract]   [Full Text] [Related]  

  • 8. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis.
    Collins CD; Brockhaus K; Sim T; Suneja A; Malani AN
    Am J Health Syst Pharm; 2019 Aug; 76(16):1219-1225. PubMed ID: 31369118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ProCommunity: procalcitonin use in real-world US community hospital settings.
    DeSear KE; Thompson-Leduc P; Kirson N; Chritton JJ; Ie S; Van Schooneveld TC; Cheung HC; Ou S; Schuetz P
    Curr Med Res Opin; 2020 Sep; 36(9):1529-1532. PubMed ID: 32643964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
    Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring both procalcitonin and C-reactive protein for a diagnosis of sepsis in critically ill patients.
    Li HX; Liu ZM; Zhao SJ; Zhang D; Wang SJ; Wang YS
    J Int Med Res; 2014 Aug; 42(4):1050-9. PubMed ID: 24827825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients - a retrospective observational study.
    Cabral L; Afreixo V; Meireles R; Vaz M; Marques M; Tourais I; Chaves C; Almeida L; Paiva JA
    BMC Anesthesiol; 2018 Sep; 18(1):122. PubMed ID: 30185148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of serum procalcitonin and hypersensitive C-reactive protein in patients with pneumonia and sepsis.
    Liu GB; Cui XQ; Wang ZB; Wen L; Duan HL
    J Biol Regul Homeost Agents; 2018; 32(5):1165-1169. PubMed ID: 30334408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice Patterns and Outcomes Associated With Procalcitonin Use in Critically Ill Patients With Sepsis.
    Chu DC; Mehta AB; Walkey AJ
    Clin Infect Dis; 2017 Jun; 64(11):1509-1515. PubMed ID: 28329238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte distribution width compared with C-reactive protein and procalcitonin for early sepsis detection in the emergency department.
    Woo A; Oh DK; Park CJ; Hong SB
    PLoS One; 2021; 16(4):e0250101. PubMed ID: 33857210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States.
    Balk RA; Kadri SS; Cao Z; Robinson SB; Lipkin C; Bozzette SA
    Chest; 2017 Jan; 151(1):23-33. PubMed ID: 27568580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Bedside Tracheostomy on Procalcitonin Kinetics in Critically Ill Patients.
    Sato K; Okajima M; Noda T; Taniguchi T
    J Intensive Care Med; 2019 Mar; 34(3):245-251. PubMed ID: 28594588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell Free DNA and Procalcitonin as Early Markers of Complications in ICU Patients with Multiple Trauma and Major Surgery.
    Ahmed AI; Soliman RA; Samir S
    Clin Lab; 2016 Dec; 62(12):2395-2404. PubMed ID: 28164563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?
    Demir NA; Sumer S; Celik G; Afsar RE; Demir LS; Ural O
    Intern Med J; 2018 Oct; 48(10):1222-1228. PubMed ID: 29717808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.